Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region-Reference-Cited by-同舟云学术

Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region

Published:2018-03-07 Issue:3 Volume:12 Page:383-411
ISSN:1750-2640
Container-title:Influenza and Other Respiratory Viruses
language:en
Short-container-title:Influenza Other Respi Viruses

Author:

Jennings Lance¹^ORCID,Huang Qiu Sue²,Barr Ian³^ORCID,Lee Ping-Ing⁴^ORCID,Kim Woo Joo⁵^ORCID,Buchy Philippe⁶^ORCID,Sanicas Melvin⁶^ORCID,Mungall Bruce A.⁶^ORCID,Chen Jing⁶^ORCID

Affiliation:

1. Canterbury District Health Board; Christchurch New Zealand

2. WHO National Influenza Centre; Institute of Environmental Science and Research; Porirua New Zealand

3. WHO Collaborating Centre for Reference and Research on Influenza; Melbourne VIC Australia

4. Department of Pediatrics; National Taiwan University Children's Hospital; Taipei Taiwan

5. Department of Internal Medicine; Korea University Guro Hospital; Seoul Korea

6. GSK; Singapore Singapore

Funder

GlaxoSmithKline Biologicals SA

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/irv.12522/fullpdf

Reference173 articles.

1. World Health Organisation Influenza (Seasonal) http://www.who.int/mediacentre/factsheets/fs211/en/

2. Impact of respiratory virus infections on persons with chronic underlying conditions;Glezen;JAMA,2000

3. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983;Rota;Virology,1990

4. Clinical and genetic characterization of severe influenza B-associated diseases during an outbreak in Taiwan;Li;J Clin Virol,2008

5. Circulation and antigenic drift in human influenza B viruses in SE Asia and Oceania since 2000;Barr;Commun Dis Intell Q Rep,2006

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of the effectiveness of non-pharmaceutical interventions on influenza during the Coronavirus disease 2019 pandemic by time-series forecasting;BMC Infectious Diseases;2023-10-24

2. Immunogenicity and safety of the quadrivalent inactivated split-virion influenza vaccine in populations aged ≥ 3 years: A phase 3, randomized, double-blind, non-inferiority clinical trial;Human Vaccines & Immunotherapeutics;2023-08

3. The clinical predictors of and vaccine protection against severe influenza infection in children;Journal of Medical Virology;2023-03

4. Differentiation of influenza B lineages circulating in different regions of Brazil, 2014–2016, using molecular assay;Vaccine: X;2022-12

5. A Comparative Analysis of Influenza-Associated Disease Burden with Different Influenza Vaccination Strategies for the Elderly Population in South Korea;Vaccines;2022-08-25